FDA OKs Aclidinium Bromide for COPD – MedPage Today

WASHINGTON — The FDA has approved aclidinium bromide (Tudorza Pressair) for long-term treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), the agency announced Monday. Aclidinium bromide, distributed by Forest …

Leave a Reply

Your email address will not be published. Required fields are marked *